Palomar Medical Stock Hits New 52-Week High (PMTI)
Palomar Medical Technologies (Nasdaq:PMTI) hit a new 52-week high Friday as it changed hands at $16.45 compared with its previous 52-week high of $16.40. Palomar Medical is currently trading at $16.45 with 101,463 shares changing hands as of 3:06 p.m..
NEW YORK ( TheStreet) -- Palomar Medical Technologies (Nasdaq: PMTI) hit a new 52-week high Friday as it traded at $16.45 compared with its previous 52-Week high of $16.40. Palomar Medical is changing hands at $16.45 with 101,463 shares traded as of 3:06 p.m. ET. Average volume has been 143,900 shares over the past 30 days. Palomar Medical has a market cap of $300.7 million and is part of the health care sector and health services industry. Shares are up 13.9% year to date as of the close of trading on Thursday. Palomar Medical Technologies, Inc., together with its subsidiaries, designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in dermatology and cosmetic procedures. TheStreet Ratings rates Palomar Medical as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Palomar Medical Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.